Daniel H. Schneiderman

Vice President of Finance, MetaStat, Inc.

Companies

Pasithea Therapeutics Corp.Chief financial officer Oct 12, 2022 to now¹
Pasithea Therapeutics Corp.Interim Chief Accting Officer Aug 15, 2022 to Aug 15, 2022²
GridAI Technologies Corp.Chief financial officer Jan 9, 2020 to Jan 3, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pasithea Therapeutics Corp. KTTA26,667 shares⁴$10.9K at $0.41Nov 28, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 28, 2025Granted 26,667 shares at $0.75 of Pasithea Therapeutics Corp.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPasithea Therapeutics Corp., Chief financial officer
2
SEC EDGARPasithea Therapeutics Corp., Interim Chief Accting Officer
3
SEC EDGARGridAI Technologies Corp., Chief financial officer
4
SEC EDGARPasithea Therapeutics Corp. shares after the filing of Nov 28, 2025